NCT03461263

Brief Summary

It has been observed that out of all visits to the clinics by the young and middle age men for grievances including the genital and urinary frameworks, about 25% of the visits account for Prostatitis. A significant number of men, aged less than 50, visits to urologist due to Interminable prostatitis. Nevertheless, just 5 to10% of "prostatitis" cases is really caused by a bacterial contamination. The purpose was to investigate thoroughly the effect of pumpkin seeds oil phonophoresis among males who are diagnosed with chronic non-bacterial prostatitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2018

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 4, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 12, 2018

Completed
Last Updated

March 12, 2018

Status Verified

March 1, 2018

Enrollment Period

11 months

First QC Date

March 4, 2018

Last Update Submit

March 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • NIH Chronic Prostatitis Symptom Index (NIH-CPSI)

    Questionnaire

    3 weeks

Study Arms (3)

Group A

ACTIVE COMPARATOR

phonophoresis treatment using pumpkin seeds oil

Other: phonophoresis treatment using pumpkin seeds oil

Group B

NO INTERVENTION

Low intensity Ultrasound

Group C

NO INTERVENTION

Placebo Low intensity Ultrasound

Interventions

phonophoresis treatment using pumpkin seeds oil

Group A

Eligibility Criteria

Age40 Years - 55 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmales with CNBP
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • For the analysis participants were recruited from a registry of patients with a diagnosis of CNBP. To be included in the analysis a patient must be evaluated with a confirmed diagnosis. They were examined and diagnosed accordingly by a medical practitioner/urologist. The patients who were included in the study should have normal laboratory findings

You may not qualify if:

  • Patients with concomitant infection, autoimmune diseases, diabetes mellitus, cancer, heart problems/pacemaker, implants (metal, silicone, saline), acute and post-acute injury, thrombophlebitis, impaired sensation, psychiatric diseases, and those with well-known contraindications of ultrasound treatment were excluded from the study. Similarly, those with known hypersensitivity to pumpkin seeds oil and its derivatives, along with those who had received other forms of therapies that could influence the therapeutic outcomes of the study were excluded from the study sample.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dr Dalia Kamel

Giza, Egypt

Location

Dr Sayed Tanatwy

Giza, Egypt

Location

Study Officials

  • Sayed A Tantawy

    Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Group A, wherein patients received phonophoresis treatment using pumpkin seeds oil; Group B, where members of the group received trans-perineal continuous low-intensity ultrasound; and Group C, in which the participant received placebo low- intensity ultrasound. All of The three groups of the organized trail received their corresponding treatment daily up-to 3 weeks.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 4, 2018

First Posted

March 12, 2018

Study Start

January 5, 2017

Primary Completion

December 13, 2017

Study Completion

February 19, 2018

Last Updated

March 12, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations